Topical treatment of ocular hypertension
    1.
    发明授权
    Topical treatment of ocular hypertension 失效
    局部治疗高眼压症

    公开(公告)号:US4477460A

    公开(公告)日:1984-10-16

    申请号:US435195

    申请日:1982-10-19

    IPC分类号: A61K31/425

    CPC分类号: A61K31/425 Y10S514/912

    摘要: This invention concerns the novel use of certain known thiazoles, particularly acylaminothiazoles and thiazolecarboxamides, as intraocular pressure lowering agents. When administered topically to the eye with increased intraocular pressure the compounds are effective in decreasing intraocular pressure, in preventing development of acute or chronic ocular hypertension including glaucoma, in inhibiting the further deterioration of the eye due to intraocular hypertension, or in relieving the symptoms of already existing ophthalmic disease.

    摘要翻译: 本发明涉及某些已知的噻唑,特别是酰氨基噻唑和噻唑甲酰胺作为眼压降低剂的新用途。 当眼内压升高时,化合物有效降低眼内压,防止急性或慢性高眼压症(包括青光眼)的发展,抑制由于眼内高血压引起的眼睛的进一步恶化,或缓解眼睛的症状 已经存在眼科疾病。

    Method for treating intraocular hypertension
    4.
    发明授权
    Method for treating intraocular hypertension 失效
    治疗眼内高血压的方法

    公开(公告)号:US4629730A

    公开(公告)日:1986-12-16

    申请号:US722038

    申请日:1985-04-11

    摘要: Elevated intraocular pressure diseases such as glaucoma are treated with compounds represented by formula I ##STR1## or a pharmaceutically acceptable acid addition salt thereof, wherein R.sub.1 is alkyl of two to four carbon atoms; andR.sub.2 is alkyl of three or four carbon atoms; orR.sub.1 and R.sub.2 taken together with N form ##STR2## wherein n is 0, 1, or 2 and R.sub.5 and R.sub.6 are each independently lower alkyl or hydro;R.sub.3 is hydro or hydroxy;R.sub.4 is hydro, lower alkyl, amino, or lower alkylamino.

    摘要翻译: 用式I(I)表示的化合物或其药学上可接受的酸加成盐处理眼内压升高的疾病如青光眼,其中R1是2-4个碳原子的烷基; R2为3或4个碳原子的烷基; 或者R 1和R 2与N一起形成,其中n是0,1或2,R 5和R 6各自独立地是低级烷基或氢; R3是氢或羟基; R4是氢,低级烷基,氨基或低级烷基氨基。

    Use of pyrrolo pyrroles in treatment of ophthalmic diseases
    5.
    发明授权
    Use of pyrrolo pyrroles in treatment of ophthalmic diseases 失效
    使用吡咯吡咯治疗眼科疾病

    公开(公告)号:US4454151A

    公开(公告)日:1984-06-12

    申请号:US360754

    申请日:1982-03-22

    摘要: Certain known pyrroles have been found to be useful in the topical treatment of various ophthalmic diseases in mammals; especially those originating from or associated with inflammation such as, for example, cystoid macular edema, glaucoma, conjunctivitis, uveitis, diabetic retinopathy and eye surgery or trauma.

    摘要翻译: 已经发现某些已知的吡咯可用于哺乳动物中各种眼科疾病的局部治疗; 特别是源于或与炎症相关的那些,例如囊性黄斑水肿,青光眼,结膜炎,葡萄膜炎,糖尿病性视网膜病变和眼科手术或创伤。

    Method for lowering intraocular pressure
    6.
    发明授权
    Method for lowering intraocular pressure 失效
    降低眼内压的方法

    公开(公告)号:US4402967A

    公开(公告)日:1983-09-06

    申请号:US256623

    申请日:1981-04-23

    IPC分类号: A61K31/415

    CPC分类号: A61K31/415

    摘要: Methods of and compositions for lowering intraocular pressure using compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each independently selected from the group consisting of hydrogen, lower alkyl, optionally substituted phenyl, and optionally substituted phenyl lower alkyl; or wherein R.sup.1 and R.sup.2 taken together form an optionally substituted benzo;R.sup.3 is hydrogen, alkyl, or optionally substituted phenyl lower alkyl;n is an integer equal to 0, 1 or 2; and the pharmaceutically acceptable acid addition salts thereof, are disclosed.

    摘要翻译: 使用式(I)的化合物降低眼内压的方法和组合物,其中R 1和R 2各自独立地选自氢,低级烷基,任选取代的苯基和任选取代的苯基低级烷基; 或其中R 1和R 2一起形成任选取代的苯并; R3是氢,烷基或任选取代的苯基低级烷基; n是等于0,1或2的整数; 及其药学上可接受的酸加成盐。

    Compositions for and a method of preventing diabetic complications
    7.
    发明授权
    Compositions for and a method of preventing diabetic complications 失效
    组合物和预防糖尿病并发症的方法

    公开(公告)号:US4232040A

    公开(公告)日:1980-11-04

    申请号:US884455

    申请日:1978-03-08

    CPC分类号: C07D311/86

    摘要: Compositions containing and methods of employing as the essential ingredients substituted xanthone carboxylic acid compounds which are useful in the prevention of complications of diabetes. Methods for preparing these compounds and the compositions and intermediates therein are also disclosed.

    摘要翻译: 含有作为必需成分的取代的呫吨酮羧酸化合物的组合物和可用于预防糖尿病并发症的方法。 还公开了制备这些化合物及其组合物和中间体的方法。

    11-substituted-16-phenoxy and 16-substituted phenoxy-prostatrienioc acid
derivatives
    10.
    发明授权
    11-substituted-16-phenoxy and 16-substituted phenoxy-prostatrienioc acid derivatives 失效
    11-取代的-16-苯氧基和16-取代的苯氧基 - 前列腺素衍生物

    公开(公告)号:US4792617A

    公开(公告)日:1988-12-20

    申请号:US18766

    申请日:1987-02-27

    IPC分类号: C07C405/00 C07C177/00

    CPC分类号: C07C405/00

    摘要: This invention covers a compound of the formula ##STR1## wherein R is hydrogen, lower alkyl or a pharmaceutically acceptable, non-toxic salt of a compound wherein R is hydrogen; X is hydrogen, halo, trifluoromethyl, lower alkyl or lower alkoxy, Y is lower alkyl or ##STR2## wherein Z is hydrogen, halo, methyl, methoxy or trifluoromethyl; and the wavy lines represent the .alpha. or .beta. configuration with the proviso that when one wavy line is .alpha. the other is .beta..

    摘要翻译: 本发明涵盖下式的化合物,其中R是氢,其中R是氢的化合物的低级烷基或药学上可接受的无毒盐; X是氢,卤素,三氟甲基,低级烷基或低级烷氧基,Y是低级烷基或者其中Z是氢,卤素,甲基,甲氧基或三氟甲基; 波浪线表示α或β配置,条件是当一条波浪线为α时,另一条波长为β。